Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 86Terminated 17Active not recruiting 12Unknown 9Withdrawn 8Recruiting 6Not yet recruiting 2No longer available 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2

Interventions

Androgen Antagonists 10darolutamide 6Magnetic Resonance Spectroscopy 6apalutamide 5Docetaxel 5enzalutamide 4Specimen Handling 4Radiotherapy 4Radiosurgery 4Abiraterone Acetate 4Electroacupuncture 3Brachytherapy 3pembrolizumab 2bicalutamide 2Standard of Care 2Resistance Training 2Radiation 2Prednisone 2Pluvicto 2Interviews as Topic 2Gonadotropin-Releasing Hormone 2Glutamate Carboxypeptidase II 2Bone Density 2Absorptiometry, Photon 2testosterone 17 beta-cypionate 1relugolix 1perflutren 1olaparib 1luprolide acetate gel depot 1fluciclovine F-18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Prostatic Neoplasms × bicalutamide × Clear all
NCT07593079 2026-05-18

Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer

Washington University School of Medicine

Phase 2 Not yet recruiting
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT07393867 2026-02-06

ARPEGGIO

Brigham and Women's Hospital

Phase 2 Not yet recruiting
23 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡